INTELLIGENT BIO SOLUTIONS INC. (INBS) Form 8-K — May 14, 2026
Intelligent Bio Solutions Inc. (INBS) reported a 46% year-over-year revenue growth for the fiscal third quarter ended March 31, 2026, with total revenue reaching $1.06 million. The company's cartridge sales, which represent 66% of Q3 revenue, increased by 59% year-over-year to $703,538. This growth is driven by the company's razor-razorblade business model, where the installed base of readers is generating strong recurring consumable demand.
Key figures
- Eps
- -1.80
- Revenue
- 1.06 million
- Net Income
- -2.86 million
- Total Debt
- 0
- Revenue Yoy
- 46%
- Cash Position
- 6.86 million
- Other sales
- 217,857
- Reader sales
- 139,407
- Capital raising
- 14.67 million
- Cartridge sales
- 703,538
- Nine month revenue
- 3.07 million
- Marketing investment
- 1.77 million
- Nine month other sales
- 535,942
- Nine month reader sales
- 672,839
- Nine month cartridge sales
- 1.86 million
- Nine month gross profit margin
- 49.3%
Price after filing
1 day: +3.0%7 days: -29.1%30 days: -40.0%
Close on the filing date to close N calendar days later (from $3.99). Historical, not a forecast.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.